Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia

NCT00646165 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Poor recruitment and change in development strategy

Conditions

B-cell Chronic Lymphocytic Leukemia

Interventions

DRUG: Forodesine

Sponsor

Mundipharma Research Limited